Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Hiemke, C' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 84 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Weigmann, H; Hartter, S; Maehrlein, S; Kiefer, W; Kramer, G; Dannhardt, G; Hiemke, C
      Simultaneous determination of olanzapine, clozapine and demethylated metabolites in serum by on-line column-switching high-performance liquid chromatography

      JOURNAL OF CHROMATOGRAPHY B
    2. Dahmen, N; Muller, MJ; Germeyer, S; Rujescu, D; Anghelescu, I; Hiemke, C; Wetzel, H
      Genetic polymorphisms of the dopamine D-2 and D-3 receptor and neurolepticdrug effects in schizophrenic patients

      SCHIZOPHRENIA RESEARCH
    3. Rao, ML; Hiemke, C; Grasmader, K; Baumann, P
      Olanzapine: Pharmacology, pharmacokinetics and therapeutic drug monitoring

      FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE
    4. Schirrmacher, R; Hamkens, W; Piel, M; Schmitt, U; Luddens, H; Hiemke, C; Rosch, F
      Radiosynthesis of (+/-)-(2-((4-(2-[F-18]fluoroethoxy)phenyl)bis(4-methoxy-phenyl) methoxy)ethylpiperidine-3-carboxylic acid: a potential GAT-3 PET ligand to study GABAergic neuro-transmission in vivo

      JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
    5. Fehr, C; Schleicher, A; Szegedi, A; Anghelescu, I; Klawe, C; Hiemke, C; Dahmen, N
      Serotonergic polymorphisms in patients suffering from alcoholism, anxiety disorders and narcolepsy

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    6. Schmitt, U; Luddens, H; Hiemke, C
      Behavioral analysis indicates benzodiazepine-tolerance mediated by the benzodiazepine binding-site at the GABA(A)-receptor

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    7. Hartter, S; Wang, XM; Weigmann, H; Friedberg, T; Arand, M; Oesch, F; Hiemke, C
      Differential effects of fluvoxamine and other antidepressants on the biotransformation of melatonin

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    8. Muller, MJ; Hartter, S; Kohler, D; Hiemke, C
      Serum levels of sulpiride enantiomers after oral treatment with racemic sulpiride in psychiatric patients: A pilot study

      PHARMACOPSYCHIATRY
    9. Weigmann, H; Gerek, S; Zeisig, A; Muller, M; Hartter, S; Hiemke, C
      Fluvoxamine but not sertraline inhibits the metabolism of olanzapine: Evidence from a therapeutic drug monitoring service

      THERAPEUTIC DRUG MONITORING
    10. Hartter, S; Weigmann, H; Hiemke, C
      Automated determination of reboxetine by high-performance liquid chromatography with column-switching and ultraviolet detection

      JOURNAL OF CHROMATOGRAPHY B
    11. Weigmann, H; Hartter, S; Bagli, M; Hiemke, C
      Steady state concentrations of clomipramine and its major metabolite desmethylclomipramine in rat brain and serum after oral administration of clomipramine

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    12. Dahmen, N; Pauly, T; Szegedi, A; Wetzel, H; Anghelescu, I; Ferdinand, K; Hiemke, C
      Adenylyl cyclase activity is increased in younger, but decreased in older,alcoholic patients after detoxification

      ALCOHOL AND ALCOHOLISM
    13. Schlosser, R; Wetzel, H; Dorr, H; Rossbach, W; Hiemke, C; Benkert, O
      Effects of subchronic paroxetine administration on night-time endocrinological profiles in healthy male volunteers

      PSYCHONEUROENDOCRINOLOGY
    14. Fehr, C; Grunder, G; Hiemke, C; Dahmen, N
      Increase in serum clomipramine concentrations caused by valproate

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    15. Fehr, C; Grintschuk, N; Szegedi, A; Anghelescu, I; Klawe, C; Singer, P; Hiemke, C; Dahmen, N
      The HTR1B 861G > C receptor polymorphism among patients suffering from alcoholism, major depression, anxiety disorders and narcolepsy

      PSYCHIATRY RESEARCH
    16. Hiemke, C; Hartter, S
      Pharmacokinetics of selective serotonin reuptake inhibitors

      PHARMACOLOGY & THERAPEUTICS
    17. Van Kampen, M; Schmitt, U; Hiemke, C; Fuchs, E
      Diazepam has no beneficial effects on stress-induced behavioural and endocrine changes in male tree shrews

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    18. Schmitt, U; Luddens, H; Hiemke, C
      Behavioral effects of GABA(A) receptor stimulation and GABA-transporter inhibition

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    19. Hartter, S; Grozinger, M; Weigmann, H; Roschke, J; Hiemke, C
      Increased bioavailability of oral melatonin after fluvoxamine coadministration

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    20. Grozinger, M; Hartter, S; Wang, XM; Roschke, J; Hiemke, C
      Fluvoxamine strongly inhibits melatonin metabolism in a patient with low-amplitude melatonin profile

      ARCHIVES OF GENERAL PSYCHIATRY
    21. Ulrich, S; Kruggel, S; Weigmann, H; Hiemke, C
      Fishing for a drug: solid-phase microextraction for the assay of clozapinein human plasma

      JOURNAL OF CHROMATOGRAPHY B
    22. Schmitt, U; Hiemke, C
      Effects of GABA-transporter (GAT) inhibitors on rat behaviour in open-field and elevated plus-maze

      BEHAVIOURAL PHARMACOLOGY
    23. Weigmann, H; Hartter, S; Fischer, V; Dahmen, N; Hiemke, C
      Distribution of clozapine and desmethylclozapine between blood and brain in rats

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    24. Reuss, S; Hermes, B; Fuchs, E; Hiemke, C
      Day- and night-time contents of monoamines and their metabolites in the medial preoptic area of the rat hypothalamus

      NEUROSCIENCE LETTERS
    25. Schmitt, U; Dahmen, N; Fischer, V; Weigmann, H; Rao, ML; Reuss, S; Hiemke, C
      Chronic oral haloperidol and clozapine in rats: A behavioral evaluation

      NEUROPSYCHOBIOLOGY
    26. Grozinger, M; Hartter, S; Hiemke, C; Roschke, J
      Oxybutynin enhances the metabolism of clomipramine and dextrorphan possibly by induction of a cytochrome P450 isoenzyme

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    27. Szegedi, A; Anghelescu, I; Wiesner, J; Schlegel, S; Weigmann, H; Hartter, S; Hiemke, C; Wetzel, H
      Addition of low-dose fluvoxamine to low-dose clozapine monotherapy in schizophrenia: Drug monitoring and tolerability data from a prospective clinical trial

      PHARMACOPSYCHIATRY
    28. Lammers, CH; Deuschle, M; Weigmann, H; Hartter, S; Hiemke, C; Heese, C; Heuser, I
      Coadministration of clozapine and fluvoxamine in psychotic patients - Clinical experience

      PHARMACOPSYCHIATRY
    29. Kramer, M; Hiemke, C; Fuchs, E
      Chronic psychosocial stress and antidepressant treatment in tree shrews: time-dependent behavioral and endocrine effects

      NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
    30. Pauly, T; Dahmen, N; Szegedi, A; Wetzel, H; Bol, GF; Ferdinand, K; Hiemke, C
      Blood ethanol levels and adenylyl cyclase activity in lymphocytes of alcoholic patients

      BIOLOGICAL PSYCHIATRY
    31. Grunder, G; Wetzel, H; Schlosser, R; Anghelescu, I; Hillert, A; Lange, K; Hiemke, C; Benkert, O
      Neuroendocrine response to antipsychotics: Effects of drug type and gender

      BIOLOGICAL PSYCHIATRY
    32. HARTTER S; JENSEN B; HIEMKE C; LEAL M; WEIGMANN H; UNGER K
      MICELLAR ELECTROKINETIC CAPILLARY CHROMATOGRAPHY FOR THERAPEUTIC DRUG-MONITORING OF CARBAMAZEPINE AND ITS MAIN METABOLITES

      Journal of chromatography B. Biomedical sciences and applications
    33. WEIGMANN H; HARTTER S; HIEMKE C
      AUTOMATED-DETERMINATION OF CLOMIPRAMINE AND ITS MAJOR METABOLITES IN HUMAN AND RAT SERUM BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH ONLINE COLUMN-SWITCHING

      Journal of chromatography B. Biomedical sciences and applications
    34. VANKAMPEN M; HIEMKE C; FUCHS E
      PSYCHOSOCIAL STRESS IN TREE SHREWS - DIAZEPAM DOES NOT COUNTERACT STRESS-INDUCED BEHAVIORAL ALTERATIONS

      European journal of neuroscience
    35. Anghelescu, I; Szegedi, A; Schlegel, S; Weigmann, H; Hiemke, C; Wetzel, H
      Combination treatment with clozapine and paroxetine in schizophrenia: safety and tolerability data from a prospective open clinical trial

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    36. GROZINGER M; HARTTER S; HIEMKE C; GRIESE EU; ROSCHKE J
      INTERACTION OF MODAFINIL AND CLOMIPRAMINE AS COMEDICATION IN A NARCOLEPTIC PATIENT

      Clinical neuropharmacology
    37. FISCHER V; SCHMITT U; WEIGMANN H; VONKELLER B; REUSS S; HIEMKE C; DAHMEN N
      CHRONICAL HALOPERIDOL AND CLOZAPINE TREATMENT IN RATS - DIFFERENTIAL RNA DISPLAY ANALYSIS, BEHAVIORAL-STUDIES AND SERUM LEVEL DETERMINATION

      Progress in neuro-psychopharmacology & biological psychiatry
    38. SCHMITT U; HIEMKE C
      COMBINATION OF OPEN-FIELD AND ELEVATED PLUS-MAZE - A SUITABLE TEST BATTERY TO ASSESS STRAIN AS WELL AS TREATMENT DIFFERENCES IN RAT BEHAVIOR

      Progress in neuro-psychopharmacology & biological psychiatry
    39. WETZEL H; ANGHELESCU I; SZEGEDI A; WIESNER J; WEIGMANN H; HARTTER S; HIEMKE C
      PHARMACOKINETIC INTERACTIONS OF CLOZAPINE WITH SELECTIVE SEROTONIN REUPTAKE INHIBITORS - DIFFERENTIAL-EFFECTS OF FLUVOXAMINE AND PAROXETINEIN A PROSPECTIVE-STUDY

      Journal of clinical psychopharmacology
    40. HARTTER S; WETZEL H; HAMMES E; TORKZADEH M; HIEMKE C
      SERUM CONCENTRATIONS OF FLUVOXAMINE AND CLINICAL EFFECTS - A PROSPECTIVE OPEN CLINICAL-TRIAL

      Pharmacopsychiatry
    41. SANDMANN J; LORCH B; BANDELOW B; HARTTER S; WINTER P; HIEMKE C; BENKERT O
      FLUVOXAMINE OR PLACEBO IN THE TREATMENT OF PANIC DISORDER AND RELATIONSHIP TO BLOOD-CONCENTRATIONS OF FLUVOXAMINE

      Pharmacopsychiatry
    42. HARTTER S; WETZEL H; HAMMES E; TORKZADEH M; HIEMKE C
      NONLINEAR PHARMACOKINETICS OF FLUVOXAMINE AND GENDER DIFFERENCES

      Therapeutic drug monitoring
    43. GERMEYER S; BIRKE A; DAHMEN N; HIEMKE C; HAVEMANNREINECKE U
      INVOLVEMENT OF THE DOPAMINE-RECEPTOR GENES IN INDIVIDUALLY DIFFERENT APOMORPHINE-INDUCED MOTILITY

      American journal of medical genetics
    44. DAHMEN N; FEHR C; SCHLEICHER A; GRUN B; QUERINGS Q; HIEMKE C
      IDENTIFYING CANDIDATE GENES IN NARCOLEPSY - THE MAINZ FAMILY STUDY

      American journal of medical genetics
    45. Szegedi, A; Anghelescu, I; Pauly, T; Dahmen, N; Muller, MJ; Wetzel, H; Hiemke, C
      Activity of the adenylyl cyclase in lymphocytes of male alcoholic patientsis state dependent

      ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
    46. SCHMITT U; HIEMKE C
      STRAIN DIFFERENCES IN OPEN-FIELD AND ELEVATED PLUS-MAZE BEHAVIOR OF RATS WITHOUT AND WITH PRETEST HANDLING

      Pharmacology, biochemistry and behavior
    47. MANN K; WAGNER P; BRUNN G; HASSAN F; HIEMKE C; ROSCHKE J
      EFFECTS OF PULSED HIGH-FREQUENCY ELECTROMAGNETIC-FIELDS ON THE NEUROENDOCRINE SYSTEM

      Neuroendocrinology
    48. HARTTER S; DINGEMANSE J; BAIER D; ZIEGLER G; HIEMKE C
      INHIBITION OF DEXTROMETHORPHAN METABOLISM BY MOCLOBEMIDE

      Psychopharmacology
    49. KOHLER D; HARTTER S; FUCHS K; SIEGHART W; HIEMKE C
      CYP2D6 GENOTYPE AND PHENOTYPING BY DETERMINATION OF DEXTROMETHORPHAN AND METABOLITES IN SERUM OF HEALTHY CONTROLS AND OF PATIENTS UNDER PSYCHOTROPIC MEDICATION

      Pharmacogenetics
    50. SCHLOSSER R; SCHLEGEL S; HIEMKE C; NICKEL O; BOCKISCH A; RAO ML; HAHN K
      [I-123] IBZM SPECT IN PATIENTS TREATED WITH TYPICAL AND ATYPICAL NEUROLEPTICS - RELATIONSHIP TO DRUG PLASMA-LEVELS AND EXTRAPYRAMIDAL SIDE-EFFECTS

      PSYCHIATRY RESEARCH-NEUROIMAGING
    51. BANGER M; HERMES B; HARTTER S; HIEMKE C
      MONITORING SERUM CONCENTRATIONS OF CLOMIPRAMINE AND METABOLITES - FLUORESCENCE POLARIZATION IMMUNOASSAY VERSUS HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY

      Pharmacopsychiatry
    52. PAULY T; SZEGEDI A; DAHMEN N; BOL GF; FERDINAND K; WETZEL H; HIEMKE C
      BLOOD ETHANOL LEVEL AND ADENYLYL-CYCLASE ACTIVITY IN LYMPHOCYTES OF ACTIVELY DRINKING ALCOHOLICS

      European journal of cell biology
    53. FEHR C; FICKOVA M; HIEMKE C; REUSS S; DAHMEN N
      MOLECULAR-CLONING OF RAT G-PROTEIN-COUPLED-RECEPTOR-KINASE-6 (GRK6) FROM BRAIN-TISSUE, AND ITS MESSENGER-RNA EXPRESSION IN DIFFERENT BRAIN-REGIONS AND PERIPHERAL-TISSUES

      Molecular brain research
    54. WEIGMANN H; BIERBRAUER J; HARTTER S; HIEMKE C
      AUTOMATED-DETERMINATION OF CLOZAPINE AND MAJOR METABOLITES IN SERUM AND URINE

      Therapeutic drug monitoring
    55. HARTLER S; KOHLER D; FUCHS C; SIEGHART W; HIEMKE C
      EFFECT OF PSYCHOTROPIC MEDICATION ON THE CYTOCHROME P4502D6 PHENOTYPE

      Naunyn-Schmiedeberg's archives of pharmacology
    56. DAHMEN N; FEHR C; REUSS S; HIEMKE C
      STIMULATION OF IMMEDIATE-EARLY GENE-EXPRESSION BY DESIPRAMINE IN RAT-BRAIN

      Biological psychiatry
    57. DEUSCHLE M; HARTTER S; HIEMKE C; STANDHARDT H; HEUSER I
      DOXEPIN AND ITS METABOLITES IN PLASMA AND CEREBROSPINAL-FLUID IN DEPRESSED-PATIENTS

      Psychopharmacology
    58. MANN K; BAUER H; HIEMKE C; ROSCHKE J; WETZEL H; BENKERT O
      ACUTE, SUBCHRONIC AND DISCONTINUATION EFFECTS OF ZOPICLONE ON SLEEP EEG AND NOCTURNAL MELATONIN SECRETION

      European neuropsychopharmacology
    59. HARTTER S; DINGEMANSE J; BAIER D; ZIEGLER G; HIEMKE C
      THE ROLE OF CYTOCHROME-P450 2D6 IN THE METABOLISM OF MOCLOBEMIDE

      European neuropsychopharmacology
    60. DAHMEN N; FISCHER V; HODL P; RUJESCU D; REUSS S; BARTOSZYK GD; HIEMKE C
      INDUCTION OF C-FOS GENE-EXPRESSION BY THE SELECTIVE SIGMA-RECEPTOR LIGAND EMD-57445 IN RAT-BRAIN

      European neuropsychopharmacology
    61. BANGER M; HIEMKE C; HAUPT M; KNUPPEN R
      EXCRETION OF 2-MONOMETHYL AND 3-MONOMETHYL ETHERS OF 2-HYDROXYESTROGENS IN HEALTHY MALE-VOLUNTEERS

      European journal of endocrinology
    62. HIEMKE C; STOLP M; REUSS S; WEVERS A; REINHARDT S; MAELICKE A; SCHLEGEL S; SCHRODER H
      EXPRESSION OF ALPHA-SUBUNIT GENES OF NICOTINIC ACETYLCHOLINE-RECEPTORS IN HUMAN-LYMPHOCYTES

      Neuroscience letters
    63. HARTTER S; BAIER D; DINGEMANSE J; ZIEGLER G; HIEMKE C
      AUTOMATED-DETERMINATION OF DEXTROMETHORPHAN AND ITS MAIN METABOLITES IN HUMAN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AND COLUMN-SWITCHING

      Therapeutic drug monitoring
    64. SZEGEDI A; WETZEL H; LEAL M; HARTTER S; HIEMKE C
      COMBINATION TREATMENT WITH CLOMIPRAMINE AND FLUVOXAMINE - DRUG-MONITORING, SAFETY, AND TOLERABILITY DATA

      The Journal of clinical psychiatry
    65. FUCHS E; KRAMER M; HERMES B; NETTER P; HIEMKE C
      PSYCHOSOCIAL STRESS IN TREE SHREWS - CLOMIPRAMINE COUNTERACTS BEHAVIORAL AND ENDOCRINE CHANGES

      Pharmacology, biochemistry and behavior
    66. SCHLEGEL S; SCHLOSSER R; HIEMKE C; NICKEL O; BOCKISCH A; HAHN K
      PROLACTIN PLASMA-LEVELS AND D-2-DOPAMINE RECEPTOR OCCUPANCY MEASURED WITH IBZM-SPECT

      Psychopharmacology
    67. JUSSOFIE A; KORNER I; SCHELL C; HIEMKE C
      TIME-COURSE OF THE EFFECTS OF STEROID-HORMONE DEPRIVATION ELICITED BYOVARIECTOMY OR OVARIECTOMY PLUS ADRENALECTOMY ON THE AFFINITY AND DENSITY OF GABA BINDING-SITES IN DISTINCT RAT-BRAIN AREAS

      EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    68. HIEMKE C; BRUNNER R; HAMMES E; MULLER H; ZUMBUSCHENFELDE KHM; LOHSE AW
      CIRCADIAN VARIATIONS IN ANTIGEN-SPECIFIC PROLIFERATION OF HUMAN T-LYMPHOCYTES AND CORRELATION TO CORTISOL PRODUCTION

      Psychoneuroendocrinology
    69. SZEGEDI A; WIESNER J; HIEMKE C
      IMPROVED EFFICACY AND FEWER SIDE-EFFECTS UNDER CLOZAPINE TREATMENT AFTER ADDITION OF FLUVOXAMINE

      Journal of clinical psychopharmacology
    70. HARTTER S; HERMES B; HIEMKE C
      AUTOMATED-DETERMINATION OF TRIMIPRAMINE AND N-DESMETHYLTRIMIPRAMINE IN HUMAN PLASMA OR SERUM BY HPLC WITH ONLINE SOLID-PHASE EXTRACTION

      Journal of liquid chromatography
    71. GRUNDER G; WETZEL H; HILLERT A; JOCHUM E; HIEMKE C; BENKERT O
      THE NEUROENDOCRINOLOGICAL PROFILE OF ROXINDOLE, A DOPAMINE AUTORECEPTOR AGONIST, IN SCHIZOPHRENIC-PATIENTS

      Psychopharmacology
    72. HARTTER S; ARAND M; OESCH F; HIEMKE C
      NONCOMPETITIVE INHIBITION OF CLOMIPRAMINE N-DEMETHYLATION BY FLUVOXAMINE

      Psychopharmacology
    73. HIEMKE C
      PHARMACOKINETICS AND PHARMACODYNAMICS OF PAROXETINE

      Fortschritte der Neurologie, Psychiatrie
    74. HERMES B; HIEMKE C; REUSS S
      DAYTIME AND NIGHTTIME CONTENT OF MONOAMINES AND THEIR METABOLITES IN THE PINEAL-GLAND OF RAT AND HAMSTER

      Neuroscience letters
    75. HIEMKE C; WEIGMANN H; HARTTER S; DAHMEN N; WETZEL H; MULLER H
      ELEVATED LEVELS OF CLOZAPINE IN SERUM AFTER ADDITION OF FLUVOXAMINE

      Journal of clinical psychopharmacology
    76. SEILER W; WETZEL H; HILLERT A; SCHOLLNHAMMER G; BENKERT O; HIEMKE C
      PLASMA-LEVELS OF BENPERIDOL, PROLACTIN, AND HOMOVANILLIC-ACID AFTER INTRAVENOUS VERSUS 2 DIFFERENT KINDS OF ORAL APPLICATION OF THE NEUROLEPTIC IN SCHIZOPHRENIC-PATIENTS

      Experimental and clinical endocrinology
    77. HARTTER S; HERMES B; SZEGEDI A; HIEMKE C
      AUTOMATED-DETERMINATION OF PAROXETINE AND ITS MAIN METABOLITE BY COLUMN-SWITCHING AND ONLINE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY

      Therapeutic drug monitoring
    78. WETZEL H; WIESNER J; HIEMKE C; BENKERT O
      ACUTE ANTAGONISM OF DOPAMINE D-2-LIKE RECEPTORS BY AMISULPRIDE - EFFECTS ON HORMONE-SECRETION IN HEALTHY-VOLUNTEERS

      Journal of Psychiatric Research
    79. SEILER W; MULLER H; HIEMKE C
      INTERLEUKIN-6 IN PLASMA COLLECTED WITH AN INDWELLING CANNULA REFLECTSLOCAL, NOT SYSTEMIC, CONCENTRATIONS

      Clinical chemistry
    80. RAO ML; STABEROCK U; BAUMANN P; HIEMKE C; DEISTER A; CUENDET C; AMEY M; HARTTER S; KRAEMER M
      MONITORING TRICYCLIC ANTIDEPRESSANT CONCENTRATIONS IN SERUM BY FLUORESCENCE POLARIZATION IMMUNOASSAY COMPARED WITH GAS-CHROMATOGRAPHY AND HPLC

      Clinical chemistry
    81. SEILER W; WETZEL H; HILLERT A; SCHOLLNHAMMER G; LANGER M; BARLAGE U; HIEMKE C
      PHARMACOKINETICS AND BIOAVAILABILITY OF BENPERIDOL IN SCHIZOPHRENIC-PATIENTS AFTER INTRAVENOUS AND 2 DIFFERENT KINDS OF ORAL APPLICATION

      Psychopharmacology
    82. JUSSOFIE A; SCHMIZ A; HIEMKE C
      KAVAPYRONE ENRICHED EXTRACT FROM PIPER METHYSTICUM AS MODULATOR OF THE GABA BINDING-SITE IN DIFFERENT REGIONS OF RAT-BRAIN

      Psychopharmacology
    83. BANGER M; MANN K; HIEMKE C
      MOOD AND CRAVING SELF-ASSESSMENT RELATED TO ENDOCRINE ALTERATIONS DURING ACUTE ALCOHOL-WITHDRAWAL

      Neuropsychopharmacology
    84. SEILER W; HIEMKE C
      DETERMINATION OF HOMOVANILLIC-ACID IN HUMAN PLASMA USING HPLC WITH ELECTROCHEMICAL DETECTION AND AUTOMATED SOLID-PHASE EXTRACTION

      Journal of liquid chromatography


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 09/12/19 alle ore 14:50:15